Literature DB >> 3136908

Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma.

C Marcelli1, D Chappard, J F Rossi, J Jaubert, C Alexandre, P Dessauw, P Baldet, R Bataille.   

Abstract

In a prospective study of the quantitative bone changes induced by B-cell cancers other than multiple myeloma (MM), but including chronic lymphocytic leukemia (CLL; n = 8), hairy cell leukemia (HCL; n = 3), and Waldenström disease (WD; n = 7), an abnormal bone remodeling close to malignant cells was found in 80% of the patients. This was observed more frequently in cases of diffuse, but not nodular, bone marrow involvement by tumor cells. More particularly, excessive bone resorption (a major feature of MM) associated with a normal to low bone formation (i.e., uncoupling bone disease) was the most frequent feature and in the same range of that observed in overt MM. However, as opposed to MM, this bone resorption was characteristically mediated by small mononucleated osteoclasts (i.e., microresorption). The same phenomena of abnormal bone remodeling, the uncoupling process, excessive bone resorption, and above all microresorption were confirmed by the detailed bone study of five cases of B-cell cancers other than MM presenting lytic bone lesions and hypercalcemia. The current findings are important for clarifying the biology of these B-cell malignant diseases, and also could be of diagnostic and prognostic value.

Entities:  

Mesh:

Year:  1988        PMID: 3136908     DOI: 10.1002/1097-0142(19880915)62:6<1163::aid-cncr2820620620>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Pathologic fracture occurring 22 years after diagnosis of hairy cell leukemia: case report and literature review.

Authors:  K S Snell; M M O'Brien; K Sendelbach; R Martino
Journal:  West J Med       Date:  1999-03

2.  Growth and dissemination of a newly-established murine B-cell lymphoma cell line is inhibited by multimeric YIGSR peptide.

Authors:  T Michigami; M Nomizu; Y Yamada; C Dunstan; P J Williams; G R Munday; T Yoneda
Journal:  Clin Exp Metastasis       Date:  1998-10       Impact factor: 5.150

3.  Increased risk of axial fractures in patients with untreated chronic lymphocytic leukemia: a population-based analysis.

Authors:  Adam J Olszewski; Roee Gutman; Charles B Eaton
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941

4.  Recruitment of new osteoblasts and osteoclasts is the earliest critical event in the pathogenesis of human multiple myeloma.

Authors:  R Bataille; D Chappard; C Marcelli; P Dessauw; P Baldet; J Sany; C Alexandre
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

5.  Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation.

Authors:  Scott A Ely; Daniel M Knowles
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Osteoclast cytomorphometry demonstrates an abnormal population in B cell malignancies but not in multiple myeloma.

Authors:  D Chappard; J F Rossi; R Bataille; C Alexandre
Journal:  Calcif Tissue Int       Date:  1991-01       Impact factor: 4.333

Review 7.  Cancer-associated bone disease.

Authors:  R Rizzoli; J-J Body; M-L Brandi; J Cannata-Andia; D Chappard; A El Maghraoui; C C Glüer; D Kendler; N Napoli; A Papaioannou; D D Pierroz; M Rahme; C H Van Poznak; T J de Villiers; G El Hajj Fuleihan
Journal:  Osteoporos Int       Date:  2013-10-22       Impact factor: 4.507

8.  Quantification of dendritic cells and osteoclasts in the bone marrow of patients with monoclonal gammopathy.

Authors:  Nicolas Josselin; Hélène Libouban; Mamoun Dib; Norbert Ifrah; Erick Legrand; Michel Félix Baslé; Maurice Audran; Daniel Chappard
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

9.  Chronic lymphocytic leukemia cells impair osteoblastogenesis and promote osteoclastogenesis: role of TNFα, IL-6 and IL-11 cytokines.

Authors:  Paolo Giannoni; Cecilia Marini; Giovanna Cutrona; Serena Matis; Maria Cristina Capra; Francesca Puglisi; Paola Luzzi; Simona Pigozzi; Gabriele Gaggero; Antonino Neri; Katia Todoerti; Fortunato Morabito; Adalberto Ibatici; Maurizio Miglino; Micaela Bergamaschi; Silvia Bruno; Gian Mario Sambuceti; Jean Louis Ravetti; Manlio Ferrarini; Franco Fais; Daniela de Totero
Journal:  Haematologica       Date:  2021-10-01       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.